|
|
||||||||
Clinical Chemistry, Vol 37, 1534-1539, Copyright © 1991 by American Association for Clinical Chemistry
GF Blackburn, HP Shah, JH Kenten, J Leland, RA Kamin, J Link, J Peterman, MJ Powell, A Shah and DB Talley
IGEN, Inc., Rockville, MD 20852.
Electrochemiluminescence (ECL) has been developed as a highly sensitive process in which reactive species are generated from stable precursors (i.e., the ECL-active label) at the surface of an electrode. This new technology has many distinct advantages over other detection systems: no radioisotopes are used; detection limits for label are extremely low (200 fmol/L); the dynamic range for label quantification extends over six orders of magnitude; the labels are extremely stable compared with those of most other chemiluminescent systems; the labels, small molecules (approximately 1000 Da), can be used to label haptens or large molecules, and multiple labels can be coupled to proteins or oligonucleotides without affecting immunoreactivity, solubility, or ability to hybridize; because the chemiluminescence is initiated electrochemically, selectivity of bound and unbound fractions can be based on the ability of labeled species to access the electrode surface, so that both separation and nonseparation assays can be set up; and measurement is simple and rapid, requiring only a few seconds. We illustrate ECL in nonseparation immunoassays for digoxin and thyrotropin and in separation immunoassays for carcinoembryonic antigen and alpha-fetoprotein. The application of ECL for detection of polymerase chain reaction products is described and exemplified by quantifying the HIV1 gag gene.
The following articles in journals at HighWire Press have cited this article:
![]() |
M. Thaler, J. Metzger, A. Schreiegg, B. Denk, A. Gleixner, H. Hauptmann, and P. B. Luppa Immunoassay for Sex Hormone-Binding Globulin in Undiluted Serum Is Influenced by High-Molecular-Mass Aggregates Clin. Chem., February 1, 2005; 51(2): 401 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rej Clinical Chemistry through Clinical Chemistry: A Journal Timeline Clin. Chem., December 1, 2004; 50(12): 2415 - 2458. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.C. A. Chan, L. C.W. Lit, E. L.K. Law, M. H.L. Tai, C.U. Yung, M. H.M. Chan, and C. W.K. Lam Diminished Urinary Free Cortisol Excretion in Patients with Moderate and Severe Renal Impairment Clin. Chem., April 1, 2004; 50(4): 757 - 759. [Full Text] [PDF] |
||||
![]() |
R. Golla and R. Seethala A Sensitive, Robust High-Throughput Electrochemiluminescence Assay for Rat Insulin J Biomol Screen, February 1, 2004; 9(1): 62 - 70. [Abstract] [PDF] |
||||
![]() |
A. H. Peruski and L. F. Peruski Jr. Immunological Methods for Detection and Identification of Infectious Disease and Biological Warfare Agents Clin. Vaccine Immunol., July 1, 2003; 10(4): 506 - 513. [Full Text] [PDF] |
||||
![]() |
S.-J. L. Wu, E. M. Lee, R. Putvatana, R. N. Shurtliff, K. R. Porter, W. Suharyono, D. M. Watts, C.-C. King, G. S. Murphy, C. G. Hayes, et al. Detection of Dengue Viral RNA Using a Nucleic Acid Sequence-Based Amplification Assay J. Clin. Microbiol., August 1, 2001; 39(8): 2794 - 2798. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Franco, E. de Jonge, P. E. P. Dekkers, J. J. Timmerman, C. A. Spek, S. J. H. van Deventer, P. van Deursen, L. van Kerkhoff, B. van Gemen, H. ten Cate, et al. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation Blood, July 15, 2000; 96(2): 554 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Romano, S. Tetali, E. M. Lee, R. N. Shurtliff, X. P. Wang, S. Pahwa, M. H. Kaplan, and C. C. Ginocchio Genotyping of the CCR5 Chemokine Receptor by Isothermal NASBA Amplification and Differential Probe Hybridization Clin. Vaccine Immunol., November 1, 1999; 6(6): 959 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamaguchi, T. Sawada, T. Naraki, R. Igata-Yi, H. Shiraki, Y. Horii, T. Ishii, K. Ikeda, N. Asou, H. Okabe, et al. Detection of Borna Disease Virus-Reactive Antibodies from Patients with Psychiatric Disorders and from Horses by Electrochemiluminescence Immunoassay Clin. Vaccine Immunol., September 1, 1999; 6(5): 696 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. de Baar, A. M. van der Schoot, J. Goudsmit, F. Jacobs, R. Ehren, K. H. M. van der Horn, P. Oudshoorn, F. de Wolf, and A. de Ronde Design and Evaluation of a Human Immunodeficiency Virus Type 1 RNA Assay Using Nucleic Acid Sequence-Based Amplification Technology Able To Quantify Both Group M and O Viruses by Using the Long Terminal Repeat as Target J. Clin. Microbiol., June 1, 1999; 37(6): 1813 - 1818. [Abstract] [Full Text] |
||||
![]() |
C. D. O'Connell, A. Juhasz, C. Kuo, D. J. Reeder, and D. S. B. Hoon Detection of tyrosinase mRNA in melanoma by reverse transcription-PCR and electrochemiluminescence Clin. Chem., June 1, 1998; 44(6): 1161 - 1169. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-T. Ma, T. Hsieh, M. E. Forbes, J. E. Johnson, and D. O. Frost BDNF Injected into the Superior Colliculus Reduces Developmental Retinal Ganglion Cell Death J. Neurosci., March 15, 1998; 18(6): 2097 - 2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Burks, G. Chen, G. Georgiou, and B. L. Iverson In vitro scanning saturation mutagenesis of an antibody binding pocket PNAS, January 21, 1997; 94(2): 412 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
E T Wilkinson, S Cheifetz, and S A De Grandis Development of competitive PCR and the QPCR system 5000 as a transcription-based screen. Genome Res., June 1, 1995; 4(6): 363 - 367. [Abstract] [PDF] |
||||
![]() |
B van Gemen, P v d Wiel, R van Beuningen, P Sillekens, S Jurriaans, C Dries, R Schoones, and T Kievits The one-tube quantitative HIV-1 RNA NASBA: precision, accuracy, and application. Genome Res., February 1, 1995; 4(4): S177 - S184. [PDF] |
||||
![]() |
J G Lazar Advanced methods in PCR product detection. Genome Res., August 1, 1994; 4(1): S1 - S14. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |